Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.

Calhoun DA, Lacourci?re Y, Crikelair N, Jia Y, Glazer RD. Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension. Curr Med Res Opin. 2013 Aug; 29(8):901-10.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Amlodipine
Antihypertensive Agents
Blood Pressure
Demography
Drug Therapy, Combination
Female
Humans
Hydrochlorothiazide
Hypertension
Male
Middle Aged
Severity of Illness Index
Tetrazoles
Valine
Young Adult

authors with profiles

David Calhoun

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support